3496
X. Fan et al. / Tetrahedron Letters 51 (2010) 3493–3496
analytical data of selected compounds are presented as follows: Compound 3d:
References and notes
mp 165–167 °C; 1H NMR (400 MHz, CDCl3) d: 7.47 (t, 1H, J = 7.6 Hz, ArH), 7.56
(t, 1H, J = 7.6 Hz, ArH), 7.80 (d, 2H, J = 8.0 Hz, ArH), 7.96 (d, 1H, J = 8.0 Hz, ArH),
8.13 (d, 1H, J = 8.0 Hz), 8.22 (d, 2H, J = 8.0 Hz, ArH). 13C NMR (100 MHz, CDCl3)
d: 114.1, 118.3, 121.8, 123.8, 126.1, 126.8, 127.9, 132.8, 135.3, 137.5, 154.0,
165.3. MS: m/z 237 (MH)+. Compound 3l: mp 185–187 °C; 1H NMR (400 MHz,
CDCl3) d: 7.43 (dd, 1H, J1 = 2.0 Hz, J2 = 8.4 Hz, ArH), 7.87 (d, 1H, J = 8.4 Hz, ArH),
8.10 (d, 1H, J = 2.0 Hz, ArH), 8.24 (d, 2H, J = 8.4 Hz), 8.36 (d, 2H, J = 8.4 Hz, ArH).
13C NMR (100 MHz, CDCl3) d: 122.6, 123.6, 124.4, 126.7, 128.3, 132.9, 133.7,
138.7, 149.1, 154.8, 166.6. MS: m/z 291 (MH)+. Compound 3t: oil; 1H NMR
(400 MHz, CDCl3) d: 1.07 (t, 3H, J = 7.6 Hz, CH3), 1.90–1.96 (m, 2H, CH2), 3.11 (t,
2H, J = 7.6 Hz, CH2), 7.35 (t, 1H, J = 7.6 Hz, ArH), 7.46 (t, 1H, J = 7.6 Hz, ArH), 7.85
(d, 1H, J = 8.0 Hz, ArH), 7.98 (d, 1H, J = 8.0 Hz). 13C NMR (100 MHz, CDCl3) d:
13.7, 23.1, 36.2, 121.4, 122.5, 124.6, 125.8, 126.6, 126.8, 135.1, 153.2, 172.2.
MS: m/z 178 (MH)+. Compound 3w: mp 207–210 °C; 1H NMR (400 MHz, CDCl3)
d: 7.39 (t, 1H, J = 8.0 Hz, ArH), 7.58 (dd, 1H, J1 = 8.0 Hz, J2 = 0.8 Hz, ArH), 7.85
(dd, 1H, J1 = 8.0 Hz, J2 = 0.8 Hz, ArH), 8.30 (d, 2H, J = 8.8 Hz, ArH), 8.36 (d, 2H,
J = 8.8 Hz, ArH). 13C NMR (100 MHz, CDCl3) d: 120.3, 124.3, 126.7, 127.1, 128.5,
129.0, 136.8, 138.6, 149.3, 151.1, 165.5. MS: m/z 291 (MH)+. Compound 3z: mp
193–195 °C; 1H NMR (400 MHz, CDCl3) d: 2.49 (s, 3H, CH3), 7.30 (d, 1H,
J = 8.0 Hz, ArH), 7.60 (d, 2H, J = 8.0 Hz, ArH), 7.66 (s, 1H, ArH), 7.91–7.94 (m, 3H,
ArH). 13C NMR (100 MHz, CDCl3) d: 21.5, 121.3, 122.8, 125.1, 128.0, 128.7,
132.1, 132.7, 135.2, 135.6, 152.2, 165.5. MS: m/z 304 (MH)+.
1. Lion, C. J.; Matthews, C. S.; Wells, G.; Bradshaw, T. D.; Stevens, M. F. G.;
Westwell, A. D. Bioorg. Med. Chem. Lett. 2006, 16, 5005.
2. Vicini, P.; Geronikaki, A.; Incerti, M.; Busonera, B.; Poni, G.; Cabras, C. A.; Colla,
P. L. Bioorg. Med. Chem. 2003, 11, 4785.
3. Zajac, M.; Hrobárik, P.; Magdolen, P.; Foltínová, P.; Zahradník, P. Tetrahedron
2008, 64, 10605.
4. Cressier, D.; Prouillac, C.; Hernandez, P.; Amourette, C.; Diserbo, M.; Lion, C.;
Rima, G. Bioorg. Med. Chem. 2009, 17, 5275.
5. (a) Zhang, X. H.; Wong, O. Y.; Gao, Z. Q.; Lee, C. S.; Kwong, H. L.; Lee, S. T.; Wu, S.
K. Mater. Sci. Eng. 2001, B85, 182; (b) Zhang, L.; Xu, Q. F.; Lu, J. M.; Li, N. J.; Yan,
F.; Wang, L. H. Polymer 2009, 50, 4807; (c) Bae, J. S.; Gwon, S. Y.; Son, Y. A.; Kim,
S. H. Dyes Pigments 2009, 83, 324; (d) Dutta, G. K.; Guha, S.; Patil, S. Org.
Electron. 2010, 11, 1; (e) Chen, L. Q.; Yang, C. L.; Qin, J. G. Spectrochim. Acta, Part
A 2007, 68, 317.
6. Itoh, T.; Nagata, K.; Ishikawa, H.; Ohsawa, A. Heterocycles 2004, 63, 2769. and
references cited therein.
7. Kawashita, Y.; Ueba, C.; Hayashi, M. Tetrahedron Lett. 2006, 47, 4231.
8. Praveen, C.; Kumar, K. H.; Muralidharan, D.; Perumal, P. T. Tetrahedron 2008, 64,
2369.
9. Bahrami, K.; Khodaei, M. M.; Naali, F. J. Org. Chem. 2008, 73, 6835.
10. Kumar, A.; Maurya, R. A.; Saxena, D. Mol. Divers. 2009. doi:10.1007/s11030-
11. (a) Pratap, U. R.; Mali, J. R.; Jawale, D. V.; Mane, R. A. Tetrahedron Lett. 2009, 50,
1352; (b) Xiao, H. L.; Chen, J. X.; Liu, M. C.; Zhu, D. J.; Ding, J. C.; Wu, H. Y. Chem.
Lett. 2009, 38, 170.
25. Peyron, C.; Benhida, R.; Bories, C.; Loiseau, P. M. Bioorg. Chem. 2005, 33, 439.
26. Ono, A.; Okamoto, T.; Inada, M.; Nara, H.; Matsuda, A. Chem. Pharm. Bull.
(Tokyo) 1994, 42, 2231.
27. Typical procedure for the preparation of 5a: A mixture containing 30,50-diacetyl-
5-formyl-20-deoxyuridine (1 mmol), o-aminobenzenethiol (2, 1 mmol), and
RuCl3 (0.05 mmol) in [bmim]PF6 (1 mL) was stirred at 80 °C for 2 h. Upon
completion, the crude product was purified by column chromatography
eluting with hexane/ethyl acetate (20–50%) to give 5a. Details of analytical
data of selected compounds are presented as follows: Compound 5a: mp 223–
225 °C; 1H NMR (400 MHz, CDCl3) d: 2.16 (s, 3H, CH3), 2.28 (s, 3H, CH3), 2.32–
2.62 (m, 2H, CH2), 4.40–4.49 (m, 3H, CH, CH2), 5.36–5.38 (m, 1H, CH), 6.48–6.52
(m, 1H, CH), 7.38 (t, 1H, J = 7.6 Hz, ArH), 7.49 (t, 1H, J = 7.6 Hz, ArH), 7.92–7.95
(m, 2H, ArH), 9.01 (s, 1H, CH), 9.36 (s, 1H, NH). 13C NMR (100 MHz, CDCl3) d:
20.9, 21.1, 38.5, 64.2, 74.7, 83.0, 85.9, 109.4, 121.6, 122.2, 124.7, 126.3, 135.7,
139.3, 149.2, 151.8, 158.4, 160.8, 170.4, 170.6. MS: m/z 446 (MH)+. Compound
5c: mp 206–207 °C; 1H NMR (400 MHz, DMSO-d6) d: 2.15 (s, 3H, CH3), 2.50–
2.62 (m, 2H, CH2), 4.21–4.55 (m, 4H, 2 ꢀ CH, CH2), 6.13–6.18 (m, 1H, CH), 7.39
(t, 1H, J = 7.6 Hz, ArH), 7.51 (t, 1H, J = 7.6 Hz, ArH), 7.89 (d, 1H, J = 7.6 Hz, ArH),
8.09 (d, 1H, J = 7.6 Hz, ArH), 8.85 (s, 1H, CH), 12.12 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6) d: 21.2, 37.7, 60.5, 63.6, 82.3, 86.4, 107.4, 121.9, 122.4,
124.9, 126.8, 135.2, 140.8, 149.5, 151.8, 159.9, 161.8, 170.8. MS: m/z 429
(MH)+. Compound 5d mp: 224–226 °C; 1H NMR (400 MHz, DMSO-d6) d: 2.10 (s,
3H, CH3), 2.48–2.63 (m, 2H, CH2), 4.21–4.48 (m, 4H, 2 ꢀ CH, CH2), 6.11–6.14
(m, 1H, CH), 7.40 (d, 1H, J = 8.4 Hz, ArH), 7.85 (s, 1H, ArH), 8.09 (d, 1H,
J = 8.4 Hz, ArH), 8.82 (s, 1H, CH), 12.10 (s, 1H, NH). 13C NMR (100 MHz, DMSO-
d6) d: 21.1, 37.8, 60.6, 63.6, 82.4, 86.7, 107.1, 121.2, 124.0, 124.9, 131.4, 134.0,
141.3, 149.5, 152.8, 161.9, 162.4, 170.7. MS: m/z 463 (MH)+. Compound 5i: mp:
199–202 °C; 1H NMR (400 MHz, DMSO-d6) d: 2.01 (s, 3H, CH3), 2.07 (s, 3H,
CH3), 2.48–2.50 (m, 2H, CH2), 4.26–4.38 (m, 3H, CH2, CH), 5.25 (s, 1H, CH),
6.18–6.22 (m, 1H, CH), 7.35 (t, 1H, J = 8.0 Hz, ArH), 7.55 (d, 1H, J = 8.0 Hz, ArH),
8.04 (d, 1H, J = 8.0 Hz, ArH), 8.90 (s, 1H, CH), 12.14 (s, 1H, NH). 13C NMR
(100 MHz, DMSO-d6) d: 21.1, 21.2, 38.0, 64.1, 74.7, 82.9, 87.2, 107.3, 121.4,
125.7, 126.0, 126.7, 136.9, 141.2, 148.6, 149.6, 161.2, 161.9, 170.4, 170.5. MS:
m/z 480 (MH)+.
12. Ito, S.; Aihara, K.; Matsumoto, M. Tetrahedron Lett. 1983, 24, 5249.
13. Komiya, N.; Noji, S.; Murahashi, S.-I. Chem. Commun. 2001, 65.
14. Sharma, N. K.; Ganesh, K. N. Tetrahedron Lett. 2004, 45, 1403.
15. Mashraqui, S. H.; Karnik, M. A. Tetrahedron Lett. 1998, 39, 4895.
16. Yusubov, M. S.; Chi, K.-W.; Park, J. Y.; Karimov, R.; Zhdankin, V. V. Tetrahedron
Lett. 2006, 47, 6305.
17. Sharma, V. B.; Jain, S. L.; Sain, B. Tetrahedron Lett. 2004, 45, 4281.
18. Plietker, B.; Niggemann, M. J. Org. Chem. 2005, 70, 2402.
19. Murahashi,S.-I.;Komiya,N.;Terai,H.;Nakae,T.J.Am.Chem.Soc. 2003,125,15312.
20. (a) Ranke, J.; Stolte, S.; Strörmann, R.; Arning, J.; Jastorff, B. Chem. Rev. 2007,
107, 2183; (b) Stolte, S.; Matzke, M.; Arning, J.; Böschen, A.; Pitner, W. R.; Welz-
Biermann, U.; Jastorff, B.; Ranke, R. Green Chem. 2007, 9, 1170.
21. (a) Afonso, C. A. M.; Branco, L. C.; Candeias, N. R.; Gois, P. M. P.; Lourenco, N. M.
T.; Mateus, N. M. M.; Rosa, J. N. Chem. Commun. 2007, 2669; (b) Pârvulescu, V.
I.; Hardacre, C. Chem. Rev. 2007, 107, 2615.
22. (a) Martins, M. A.; Frizzo, C. P.; Moreira, D. N.; Zanatta, N.; Bonacorso, H. G.
Chem. Rev. 2008, 108, 2015; (b) Charkraborti, A. K.; Roy, S. R. J. Am. Chem. Soc.
2009, 131, 6902.
23. (a) Fan, X.; Hu, X.; Zhang, X.; Wang, J. Aust. J. Chem. 2004, 57, 1067; (b) Fan, X.;
Hu, X.; Zhang, X.; Wang, J. Can. J. Chem. 2005, 83, 16; (c) Fan, X.; Li, Y.; Zhang,
X.; Wang, J. Can. J. Chem. 2006, 84, 794; (d) Zhang, X.; Fan, X.; Niu, H.; Wang, J.
Green Chem. 2003, 5, 267.
24. Typical procedure for the preparation of 3a: A mixture containing aldehyde (1a,
1 mmol), o-aminobenzenethiol (2a, 1 mmol), and RuCl3 (0.05 mmol) in
[bmim]PF6 (1 mL) was stirred at 80 °C for 0.5 h. Upon completion, the
mixture was extracted with diethyl ether (10 mL ꢀ 3). The combined organic
phases were washed with H2O and dried over MgSO4, filtered, and
concentrated under vacuum. The crude product was purified by column
chromatography eluting with hexane/ethyl acetate (5–20%) to give 3a. Other 2-
substituted benzothiazoles were obtained in a similar manner. Details of